MedPath
HSA Approval

SUNTHORPHAN SYRUP 15MG/5ML

SIN13992P

SUNTHORPHAN SYRUP 15MG/5ML

SUNTHORPHAN SYRUP 15MG/5ML

July 29, 2011

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05DA09

dextromethorphan

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Sunward Pharmaceutical Sdn. Bhd.

Active Ingredients

DEXTROMETHORPHAN 10.99 mg/5 ml EQV DEXTROMETHORPHAN HYDROBROMIDE

15mg/5ml

Dextromethorphan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.